Elsevier

Genomics

Volume 11, Issue 2, October 1991, Pages 490-491
Genomics

Special feature
Call for a worldwide survey of human genetic diversity: A vanishing opportunity for the Human Genome Project

https://doi.org/10.1016/0888-7543(91)90169-FGet rights and content

References (12)

  • A.M. Bowcock et al.

    Drift, admixture, and selection in human evolution: A study with DNA polymorphisms

  • R.L. Cann et al.

    Mitochondrial DNA and human evolution

    Nature

    (1987)
  • L.L. Cavalli-Sforza

    How can one study individual variation for 3 billion nucleotides of the human genome?

    Am. J. Hum. Genet

    (1991)
  • L.L. Cavalli-Sforza et al.

    DNA markers and genetic variation in the human species

  • L.L. Cavalli-Sforza et al.
  • L.L. Cavalli-Sforza et al.

    Reconstruction of human evolution: Bringing together genetic, archaeological, and linguistic data

There are more references available in the full text version of this article.

Cited by (150)

  • L. Luca Cavalli-Sforza: A Renaissance Scientist

    2020, Theoretical Population Biology
  • Microhaplotypes in forensic genetics

    2019, Forensic Science International: Genetics
    Citation Excerpt :

    With the goal of establishing a resource for the study of global variation in the human genome, the HGDP-CEPH (Human Genome Diversity Panel - Centre d’Etude du Polymorphisme Humain) was established in 2002. At its core the HGDP-CEPH [17,18] is a collection of 1064 cultured lymphoblastoid cell lines from 52 populations of different parts of the world deposited at the Foundation Jean Dausset in Paris. Later studies, aimed at understanding human evolution and population structure [19,20] focused on linkage disequilibrium (LD).

  • High-resolution HLA-A, HLA-B, and HLA-DRB1 haplotype frequencies from the French Bone Marrow Donor Registry

    2015, Human Immunology
    Citation Excerpt :

    Estimations of human leukocyte antigen (HLA) haplotype frequencies from unrelated hematopoietic stem cell donor registries provide valuable results because they are estimated from the largest sample available. Although large-scale research sampling in the genomic era [1–3] and in large population cohorts of epidemiological interest have been collected (B58 cohort) [4,5], none of these compare the sample sizes required to find a suitable match for patients with an indication for hematopoietic stem cell transplantation (HSCT) [6]. At the national and international levels, it is estimated that data for more than 25 million hematopoietic stem cell donors worldwide have been gathered [7,8].

  • Human Genome Diversity Project: History

    2015, International Encyclopedia of the Social & Behavioral Sciences: Second Edition
  • Precision health equity for racialized communities

    2023, International Journal for Equity in Health
View all citing articles on Scopus
View full text